MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

DexCom Inc

Fechado

SetorSaúde

68.23 1.43

Visão Geral

Variação de preço das ações

24h

Atual

Mín

66.46

Máximo

68.49

Indicadores-chave

By Trading Economics

Rendimento

17M

152M

Vendas

119M

1.1B

P/E

Médio do Setor

47.409

63.778

EPS

0.45

Margem de lucro

13.624

Funcionários

10,200

EBITDA

5M

242M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+53.59% upside

Dividendos

By Dow Jones

Próximos Ganhos

24 de abr. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-7.9B

26B

Abertura anterior

66.8

Fecho anterior

68.23

Sentimento de Notícias

By Acuity

15%

85%

26 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

DexCom Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de out. de 2024, 09:10 UTC

Ganhos

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26 de jul. de 2024, 20:16 UTC

Ganhos

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 de jul. de 2024, 09:13 UTC

Principais Notícias
Ações em Alta

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 de jul. de 2024, 08:56 UTC

Principais Notícias

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 de jun. de 2024, 16:01 UTC

Ganhos

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Comparação entre Pares

Variação de preço

DexCom Inc Previsão

Preço-alvo

By TipRanks

53.59% parte superior

Previsão para 12 meses

Média 103.4 USD  53.59%

Máximo 120 USD

Mínimo 82 USD

Com base em 18 analistas de Wall Street que oferecem metas de preço de 12 meses para DexCom Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

18 ratings

16

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

66.25 / 72.47Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

26 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.